These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16983952)

  • 1. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of cardiovascular disease and renal failure.
    Dikow R; Zeier M; Ritz E
    Cardiol Clin; 2005 Aug; 23(3):311-7. PubMed ID: 16084280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in chronic renal failure.
    Santoro D; Bellinghieri G; Conti G; Pazzano D; Satta E; Costantino G; Savica V
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S103-8. PubMed ID: 20797556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.
    Kapur V; Schwarz ER
    Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
    Stenvinkel P
    J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and the heart in chronic kidney disease.
    Zalunardo N; Levin A
    Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk in diabetic end-stage renal disease patients.
    Wang AY
    J Diabetes; 2011 Jun; 3(2):119-31. PubMed ID: 21599866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of augmenting dialysis frequency and duration on cardiovascular function.
    Ly J; Chan CT
    ASAIO J; 2006; 52(6):e11-4. PubMed ID: 17117036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual renal function - one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients.
    Huang WH; Chen KH; Hsu CW; Chen YC; Hung CC; Huang JY; Lin JL; Yang CW
    Blood Purif; 2008; 26(2):133-7. PubMed ID: 18187943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic renal disease as cardiovascular risk factor].
    Hermans MM; Kooman JP; Stehouwer CD
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1614-8. PubMed ID: 18998268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.